A University of Calgary study has found promising results for the generic drug hydroxychloroquine when used to treat the evolution of disability of primary progressive multiple sclerosis (MS), the ...
The US Food and Drug Administration (FDA) on Monday issued two new product-specific guidance documents for the unproven but highly demanded potential COVID-19 drugs chloroquine phosphate and ...
This week marks five years since March 13, 2020, the day President Donald Trump declared a national state of emergency over the novel coronavirus outbreak. The White House issued The President's ...
CALGARY, Alberta (StudyFinds.org) – Hydroxychloroquine may not be a reliable treatment for COVID-19, but a new study finds it may find a new job treating the worst form of multiple sclerosis (MS).
MISSISSAUGA, ON, April 20, 2020 /CNW/ - Mint Pharmaceuticals, one of Canada's leading generic pharmaceutical companies, is donating Hydroxychloroquine to support a critical and timely St. Joseph's ...
Plaquenil (hydroxychloroquine) is a brand-name oral tablet that’s prescribed for rheumatoid arthritis, lupus, and malaria. As with other drugs, Plaquenil can cause side effects, such as nausea, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results